Trial intelligence / Profile preview

Platelet transfusion thresholds in hematologic patients with VTE

NCT03195010Phase 2Terminated

Sponsor
Fred Hutchinson Cancer Center
Start
Jun 2017
Primary completion
Dec 2018
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of platelet transfusion in Thrombocytopenia, sponsored by Fred Hutchinson Cancer Center. Started Jun 2017; status: terminated.

02

Drugs

platelet transfusion
03

Conditions

Thrombocytopenia

Beyond the preview

Go deeper on NCT03195010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03195010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call